当前位置:首页 - 行情中心 - 拓新药业(301089) - 财务分析 - 现金流量表

拓新药业

(301089)

  

流通市值:19.35亿  总市值:27.31亿
流通股本:8964.93万   总股本:1.27亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金247,564,010.99168,937,590.1781,824,745.02279,456,032.62
  收到的税费返还2,430,844.392,308,056.11,099,914.556,329,215.11
  收到其他与经营活动有关的现金6,551,304.38908,897.6755,531.6824,452,838.95
  经营活动现金流入小计256,546,159.76172,154,543.8783,680,191.25310,238,086.68
  购买商品、接受劳务支付的现金115,652,136.4581,102,126.6338,778,473.95121,589,748.24
  支付给职工以及为职工支付的现金104,742,500.4770,079,409.1235,849,925.96139,856,823.74
  支付的各项税费10,989,396.847,143,774.373,994,937.7223,625,697.52
  支付其他与经营活动有关的现金31,180,118.218,380,757.266,466,357.8451,352,718.21
  经营活动现金流出小计262,564,151.96176,706,067.3885,089,695.47336,424,987.71
  经营活动产生的现金流量净额-6,017,992.2-4,551,523.51-1,409,504.22-26,186,901.03
二、投资活动产生的现金流量:
  收回投资收到的现金421,772,030.47211,095,074.0375,347,366.39984,823,350.64
  取得投资收益收到的现金---172,197.6
  投资活动现金流入小计421,772,030.47211,095,074.0375,347,366.39984,995,548.24
  购建固定资产、无形资产和其他长期资产支付的现金45,527,609.633,591,084.326,877,871.0244,454,904.42
  投资支付的现金400,000,000210,000,00060,000,000870,000,000
  投资活动现金流出小计445,527,609.6243,591,084.3266,877,871.02914,454,904.42
  投资活动产生的现金流量净额-23,755,579.13-32,496,010.298,469,495.3770,540,643.82
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金91,835.7391,835.7351,785.414,167.01
  筹资活动现金流入小计91,835.7391,835.7351,785.414,167.01
  支付其他与筹资活动有关的现金1,224,188.16--1,224,188.16
  筹资活动现金流出平衡项目0--0
  筹资活动现金流出小计1,224,188.16--1,224,188.16
  筹资活动产生的现金流量净额-1,132,352.4391,835.7351,785.4-1,210,021.15
四、汇率变动对现金及现金等价物的影响-866,682.65-521,201.1-290,232-287,930.55
五、现金及现金等价物净增加额-31,772,606.41-37,476,899.176,821,544.5542,855,791.09
  加:期初现金及现金等价物余额104,637,524.34104,637,524.34104,637,524.3461,781,733.25
  期末现金及现金等价物余额72,864,917.9367,160,625.17111,459,068.89104,637,524.34
补充资料:
  净利润--27,960,796.93--69,661,027.7
  资产减值准备-5,644,145.75-16,116,367.19
  固定资产和投资性房地产折旧-37,219,545.36-62,432,781.88
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-37,219,545.36-62,432,781.88
  无形资产摊销-1,420,166.1-2,881,512.27
  长期待摊费用摊销-483,309.06-876,477.19
  固定资产报废损失-19,805.06-416,386.26
  公允价值变动损失--417,019.17--147,519.18
  财务费用-584,301.65-428,331.08
  投资损失--947,554.85--4,119,715.12
  递延所得税--806,850.37--3,684,929.54
  其中:递延所得税资产减少--795,585.05--1,398,308.88
    递延所得税负债增加--11,265.32--2,286,620.66
  存货的减少--30,146,505.89--15,354,588.77
  经营性应收项目的减少-12,076,198.96--15,069,455.3
  经营性应付项目的增加--837,370.61--14,447,074.37
  现金的期末余额-67,160,625.17-104,637,524.34
  减:现金的期初余额-104,637,524.34-61,781,733.25
  现金及现金等价物的净增加额--37,476,899.17-42,855,791.09
公告日期2026-10-272026-08-282026-04-282026-03-28
审计意见(境内)标准无保留意见
TOP↑